SENP6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.408000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.016800E-01
Normal-vs-Stage2
2.737500E-02
Normal-vs-Stage3
1.455800E-01
Normal-vs-Stage4
6.820200E-01
Stage1-vs-Stage2
8.664200E-01
Stage1-vs-Stage3
1.496190E-01
Stage1-vs-Stage4
1.984380E-01
Stage2-vs-Stage3
9.602800E-04
Stage2-vs-Stage4
7.788400E-02
Stage3-vs-Stage4
1.230270E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.425900E-02
Normal-vs-AfricanAmerican
3.318200E-01
Normal-vs-Asian
5.402400E-02
Caucasian-vs-AfricanAmerican
4.165400E-01
Caucasian-vs-Asian
3.003600E-01
AfricanAmerican-vs-Asian
2.427800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.392200E-02
Normal-vs-Female
6.465600E-02
Male-vs-Female
1.226780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.570000E-01
Normal-vs-Age(41-60Yrs)
9.795800E-02
Normal-vs-Age(61-80Yrs)
2.551500E-02
Normal-vs-Age(81-100Yrs)
6.617800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.425200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.813400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.735200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.986400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.874000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.161200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.980450E-02
Normal-vs-Daily Drinker
5.555700E-03
Normal-vs-Weekly Drinker
3.069500E-02
Normal-vs-Occasional Drinker
9.781900E-02
Normal-vs-Social Drinker
2.806200E-01
Non Drinker-vs-Daily Drinker
1.895950E-01
Non Drinker-vs-Weekly Drinker
8.539000E-01
Non Drinker-vs-Occasional Drinker
4.126000E-01
Non Drinker-vs-Social Drinker
1.499430E-01
Daily Drinker-vs-Weekly Drinker
3.514400E-01
Daily Drinker-vs-Occasional Drinker
6.490100E-02
Daily Drinker-vs-Social Drinker
2.595600E-02
Weekly Drinker-vs-Occasional Drinker
4.052800E-01
Weekly Drinker-vs-Social Drinker
1.987990E-01
Occasional Drinker-vs-Social Drinker
5.378000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.975630E-01
Normal-vs-Grade 2
8.290100E-02
Normal-vs-Grade 3
9.242000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.110600E-01
Grade 1-vs-Grade 3
9.990600E-01
Grade 1-vs-Grade 4
1.975630E-01
Grade 2-vs-Grade 3
5.758600E-01
Grade 2-vs-Grade 4
8.290100E-02
Grade 3-vs-Grade 4
9.242000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.032000E-02
Normal-vs-NonDiabetic
1.866090E-02
Diabetic-vs-NonDiabetic
6.336400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.321700E-02
Normal-vs-NoPancreatitis
2.271600E-02
Pancreatitis-vs-NoPancreatitis
3.965000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.499600E-02
Normal-vs-N1
2.462000E-02
N0-vs-N1
6.767800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.845600E-01
Normal-vs-TP53-NonMutant
2.673200E-01
TP53-Mutant-vs-TP53-NonMutant
2.012400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
